{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:31:06Z","timestamp":1790127066557,"version":"4.0.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100014382","name":"Ipsen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014382","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["archives-pmr.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Physical Medicine and Rehabilitation"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.apmr.2014.03.016","type":"journal-article","created":{"date-parts":[[2014,4,4]],"date-time":"2014-04-04T16:08:53Z","timestamp":1396627733000},"page":"1303-1311","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Botulinum Toxin Type B in the Spastic Arm: A Randomized, Double-Blind, Placebo-Controlled, Preliminary Study"],"prefix":"10.1016","volume":"95","author":[{"given":"Jean-Michel","family":"Gracies","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Bayle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apmr.2014.03.016_bib1","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/mus.20285","article-title":"Pathophysiology of spastic paresis. Part II. The emergence of muscle overactivity","volume":"31","author":"Gracies","year":"2005","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.apmr.2014.03.016_bib2","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa011892","article-title":"Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke","volume":"347","author":"Brashear","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apmr.2014.03.016_bib3","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1136\/jnnp.2008.159657","article-title":"BoNT\/TZD Study Team. Botulinum neurotoxin versus tizanidine in upper limb spasticity: a placebo-controlled study","volume":"80","author":"Simpson","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.apmr.2014.03.016_bib4","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1212\/01.wnl.0000311391.00944.c4","article-title":"Assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology","volume":"70","author":"Simpson","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.apmr.2014.03.016_bib5","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.apmr.2003.08.077","article-title":"Botulinum toxin type B in upper-limb poststroke spasticity: a double-blind, placebo-controlled trial","volume":"85","author":"Brashear","year":"2004","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.apmr.2014.03.016_bib6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1053\/apmr.2003.50070","article-title":"Treatment with botulinum toxin type B for upper-limb spasticity","volume":"84","author":"Brashear","year":"2003","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.apmr.2014.03.016_bib7","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.toxicon.2009.03.009","article-title":"NeuroBloc\/Myobloc: unique features and findings","volume":"54","author":"Arezzo","year":"2009","journal-title":"Toxicon"},{"key":"10.1016\/j.apmr.2014.03.016_bib8","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1002\/mus.23427","article-title":"Spastic cocontraction in hemiparesis: effects of botulinum toxin","volume":"46","author":"Vinti","year":"2012","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.apmr.2014.03.016_bib9","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1093\/brain\/119.5.1737","article-title":"Spasticity and muscle contracture following stroke","volume":"119","author":"O'Dwyer","year":"1996","journal-title":"Brain"},{"key":"10.1016\/j.apmr.2014.03.016_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.apmr.2008.04.030","article-title":"Botulinum toxin dilution and endplate targeting in spasticity: a double-blind controlled study","volume":"90","author":"Gracies","year":"2009","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.apmr.2014.03.016_bib11","first-page":"411","article-title":"Five-step clinical assessment in spastic paresis","volume":"46","author":"Gracies","year":"2010","journal-title":"Eur J Phys Rehabil Med"},{"key":"10.1016\/j.apmr.2014.03.016_bib12","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1053\/apmr.2000.16346","article-title":"Short-term effects of dynamic Lycra splints on upper limb in hemiplegic patients","volume":"81","author":"Gracies","year":"2000","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.apmr.2014.03.016_bib13","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.apmr.2009.11.017","article-title":"Reliability of the Tardieu Scale for assessing spasticity in children with cerebral palsy","volume":"91","author":"Gracies","year":"2010","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.apmr.2014.03.016_bib14","series-title":"Handbook of botulinum toxin","first-page":"221","article-title":"Botulinum toxin in spasticity","author":"Gracies","year":"2002"},{"key":"10.1016\/j.apmr.2014.03.016_bib15","first-page":"540","article-title":"Preliminary trial of carisoprodol in multiple sclerosis","volume":"192","author":"Ashworth","year":"1964","journal-title":"Practitioner"},{"key":"10.1016\/j.apmr.2014.03.016_bib16","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000069495","article-title":"A double-blind randomized placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport) in the treatment of spastic equinovarus deformity after stroke","volume":"15","author":"Pittock","year":"2003","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.apmr.2014.03.016_bib17","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.apmr.2009.03.008","article-title":"Effect of baseline spastic hemiparesis on recovery of upper-limb function following botulinum toxin type A injections and postinjection therapy","volume":"90","author":"Chang","year":"2009","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.apmr.2014.03.016_bib18","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.apmr.2009.02.026","article-title":"A preliminary assessment of the benefits of the addition of botulinum toxin A to a conventional therapy program on the function of people with longstanding stroke","volume":"90","author":"Meythaler","year":"2009","journal-title":"Arch Phys Med Rehabil"}],"container-title":["Archives of Physical Medicine and Rehabilitation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003999314002561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003999314002561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T13:16:54Z","timestamp":1762089414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003999314002561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":18,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0003999314002561"],"URL":"https:\/\/doi.org\/10.1016\/j.apmr.2014.03.016","relation":{},"ISSN":["0003-9993"],"issn-type":[{"value":"0003-9993","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Botulinum Toxin Type B in the Spastic Arm: A Randomized, Double-Blind, Placebo-Controlled, Preliminary Study","name":"articletitle","label":"Article Title"},{"value":"Archives of Physical Medicine and Rehabilitation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apmr.2014.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}